Publikationen, an denen er mitarbeitet Antonio Jose Ruiz Alcaraz (26)

2022

  1. Analysis of the anti-inflammatory potential of Brassica bioactive compounds in a human macrophage-like cell model derived from HL-60 cells

    Biomedicine and Pharmacotherapy, Vol. 149

  2. Corrigendum to “Analysis of the anti-inflammatory potential of Brassica bioactive compounds in a human macrophage-like cell model derived from HL-60 cells” [Biomed. Pharmacother. 149 (2022) 112804](S0753332222001925)(10.1016/j.biopha.2022.112804)

    Biomedicine and Pharmacotherapy

  3. Membrane Vesicles for Nanoencapsulated SulforaphaneIncreased Their Anti-Inflammatory Role on an In Vitro Human Macrophage Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

  4. Potential of Sulforaphane and Broccoli Membrane Vesicles as Regulators of M1/M2 Human Macrophage Activity

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Recent insights into the characteristics and role of peritoneal macrophages from ascites of cirrhotic patients

    World Journal of Gastroenterology, Vol. 27, Núm. 41, pp. 7014-7024

  2. The role of peritoneal macrophages in endometriosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

2020

  1. Brassica bioactives could ameliorate the chronic inflammatory condition of endometriosis

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-20

  2. Hypothetical roadmap towards endometriosis: Prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections

    Human Reproduction Update, Vol. 26, Núm. 2, pp. 214-246

  3. Isolation of functional mature peritoneal macrophages from healthy humans

    Immunology and Cell Biology, Vol. 98, Núm. 2, pp. 114-126

2019

  1. Anti-leukemia activity of 4-amino-2-aryl-6,9-dichlorobenzo[g]pteridines

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 392, Núm. 2, pp. 219-227

  2. Expression of LAIR-1 (CD305) on human blood monocytes as a marker of hepatic cirrhosis progression

    Journal of Immunology Research, Vol. 2019

  3. Therapeutic potential of pteridine derivatives: A comprehensive review

    Medicinal Research Reviews, Vol. 39, Núm. 2, pp. 461-516

2018

  1. Caoítulo 24. Estudio piloto para el empleo de videojuegos como herramienta de aprendizaje de inmunología en alumnos de Grado de la Universidad de Murcia

    Innovación, diversidad y TIC en la enseñanza superior (Servicio de Publicaciones de la Universidad de Murcia), pp. 257-267

  2. Characterization of human peritoneal monocyte/macrophage subsets in homeostasis: Phenotype, GATA6, phagocytic/oxidative activities and cytokines expression

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Intracellular signaling modifications involved in the anti-inflammatory effect of 4-alkoxy-6,9-dichloro[1,2,4]triazolo[4,3-a]quinoxalines on macrophages

    European Journal of Pharmaceutical Sciences, Vol. 99, pp. 292-298

2016

  1. A novel CD14high CD16high subset of peritoneal macrophages from cirrhotic patients is associated to an increased response to LPS

    Molecular Immunology, Vol. 72, pp. 28-36

  2. Ascites in human liver cirrhosis

    Ascites: Aetiology, Symptoms and Treatment (Nova Science Publishers, Inc.), pp. 1-31

  3. Differences in the inflammatory status derived on aetiology in human liver cirrhosis

    Ascites: Aetiology, Symptoms and Treatment (Nova Science Publishers, Inc.), pp. 33-61

2015

  1. Inflammatory status in human hepatic cirrhosis

    World Journal of Gastroenterology, Vol. 21, Núm. 41, pp. 11522-11541

  2. Quinoxalines potential to target pathologies

    Current Medicinal Chemistry, Vol. 22, Núm. 26, pp. 3075-3108